{
    "Question": "K-BioCELF Inc. CES 2024 product highlight and specification",
    "Summary": "K-BioCELF Inc.\n\nCES 2024\n\n- Develops liquid biopsy platform for early cancer detection and prevention\n- Offers CELB ACE + ONT system for liquid biopsy platform technology\n- Utilizes circulating tumor cell (CTC) separation device technology for selecting living cancer cells\n- Provides personalized platform based on automated cell culture and sample separation and automation system\n- Offers other products and services including CELP, CELF, CELH, and customer automation system\n- Focuses on diagnostic equipment, advanced biopharmaceuticals, autoimmune disease treatment, anticancer treatment, and bio-production automation equipment",
    "Summary_cn": "K-BioCELF有限公司。\n\nCES 2024\n\n- 开发用于早期癌症检测和预防的液体活检平台\n- 提供CELB ACE + ONT系统的液体活检平台技术\n- 利用循环肿瘤细胞（CTC）分离设备技术选择活性癌细胞\n- 根据自动化细胞培养和样品分离以及自动化系统提供个性化平台\n- 提供其他产品和服务，包括CELP、CELF、CELH和客户自动化系统\n- 专注于诊断设备、先进的生物制药、自身免疫性疾病治疗、抗癌治疗和生物生产自动化设备"
}